BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12941794)

  • 1. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.
    Lieberfarb ME; Lin M; Lechpammer M; Li C; Tanenbaum DM; Febbo PG; Wright RL; Shim J; Kantoff PW; Loda M; Meyerson M; Sellers WR
    Cancer Res; 2003 Aug; 63(16):4781-5. PubMed ID: 12941794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
    Jänne PA; Li C; Zhao X; Girard L; Chen TH; Minna J; Christiani DC; Johnson BE; Meyerson M
    Oncogene; 2004 Apr; 23(15):2716-26. PubMed ID: 15048096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.
    Lips EH; Dierssen JW; van Eijk R; Oosting J; Eilers PH; Tollenaar RA; de Graaf EJ; van't Slot R; Wijmenga C; Morreau H; van Wezel T
    Cancer Res; 2005 Nov; 65(22):10188-91. PubMed ID: 16288005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.
    Tørring N; Borre M; Sørensen KD; Andersen CL; Wiuf C; Ørntoft TF
    Br J Cancer; 2007 Feb; 96(3):499-506. PubMed ID: 17245344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer.
    Hügel A; Wernert N
    Br J Cancer; 1999 Feb; 79(3-4):551-7. PubMed ID: 10027329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.
    Lin LJ; Asaoka Y; Tada M; Sanada M; Nannya Y; Tanaka Y; Tateishi K; Ohta M; Seto M; Sasahira N; Tada M; Kawabe T; Zheng CQ; Kanai F; Ogawa S; Omata M
    Oncology; 2008; 75(1-2):102-12. PubMed ID: 18787345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism array analysis of cancer.
    Dutt A; Beroukhim R
    Curr Opin Oncol; 2007 Jan; 19(1):43-9. PubMed ID: 17133111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
    Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
    Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays.
    Zhou X; Rao NP; Cole SW; Mok SC; Chen Z; Wong DT
    Cancer Genet Cytogenet; 2005 May; 159(1):53-7. PubMed ID: 15860358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Jacobs S; Thompson ER; Nannya Y; Yamamoto G; Pillai R; Ogawa S; Bailey DK; Campbell IG
    Cancer Res; 2007 Mar; 67(6):2544-51. PubMed ID: 17363572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-array multi-SNP genotyping algorithm for Affymetrix SNP microarrays.
    Xiao Y; Segal MR; Yang YH; Yeh RF
    Bioinformatics; 2007 Jun; 23(12):1459-67. PubMed ID: 17459966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
    Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Göransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hjalgrim H; Syvänen AC; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
    Genes Chromosomes Cancer; 2008 Aug; 47(8):697-711. PubMed ID: 18484635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
    Wang Z; Lai FM
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.